Pacific Biosciences of California (PACB) said Monday it closed the sale of select intellectual property and other assets to Illumina for $48.1 million in cash.
The assets were related to its short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies, the company said.
Under the terms of the agreement, Illumina assumed certain liabilities and granted a non-exclusive license certain intellectual property back to Pacific Biosciences, the company said.
Price: 2.16, Change: -0.11, Percent Change: -4.65
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments